GLP-⁠1 explained honestly: effects, limits and what can come next

Between turning point and dead end

Rarely has a treatment been as controversial as the GLP-⁠1-based weight-loss injection. For some it is a turning point, for others a medical dead end. As so often, the truth lies somewhere in between.

At Weight Doctors®, we talk every day with patients who have started GLP-⁠1 pharmacotherapy – some euphoric, some frustrated, some simply at a loss. This article aims to bring clarity: what GLP-⁠1 can do, where it reaches its limits, and how you can find the next step without the detour of trial and error.

What GLP-⁠1 is – and why it excites so many people

GLP-⁠1 (glucagon-like peptide-1) is a hormone produced by the gut that is released after eating and regulates the feeling of fullness. Modern medications contain active substances that imitate this hormone or strengthen its effect – in everyday language, this is called “GLP-⁠1 pharmacotherapy”.

The effects of GLP-⁠1 therapy: the stomach empties more slowly, the feeling of hunger is dampened, and cravings ease. Clinical studies show an average weight loss of 15 to 22.5% of body weight – more than many conventional methods achieve.

For many people worldwide, GLP-⁠1 therapy is therefore a real turning point. Besides weight, related conditions such as type 2 diabetes, high blood pressure or lipid metabolism disorders can also improve. Anyone who starts GLP-⁠1 pharmacotherapy is doing something for their health – that is also part of the truth.

15 to 22% sounds like a lot – what does it really mean?

At first glance, the study results look impressive. Behind the percentages, however, is a reality that often gets lost in the public debate – and that is crucial for you.

In practice, a weight loss of 15 to 22.5% means a reduction of around 10 to 15 kilograms for most patients – rarely more. With moderate excess weight, that may be exactly the goal. With pronounced obesity and a BMI well above 35 or 40, it is a good start, but rarely the end of the journey.

In other words: GLP-⁠1 pharmacotherapy is a powerful tool, but not a miracle cure. It brings many people to a point where they realise: there is still some way to go.

The other side – where GLP-⁠1 reaches its limits

However convincing the evidence on effectiveness is, everyday life often looks different. Dr. med. Roland Mörmel, specialist in internal medicine at Weight Doctors®, puts the international data into context:

Why many people do not reach their goal with GLP-⁠1 alone

GLP-⁠1 is not the end,
but often a building block

GLP-⁠1, gastric balloon and endo sleeve are not mutually exclusive. On the contrary: used wisely, they complement each other.

We call this bridge therapy – a well-thought-out step-by-step concept in which each treatment works where it is strongest. This is exactly what distinguishes a medical strategy from a mere product recommendation. The transition is supported by doctors and adapted to your progress.

The endo sleeve – if you are looking for a lasting solution

If you do not reach your goal with GLP-⁠1 pharmacotherapy – or want a one-off, lasting solution from the start –, you will find an alternative to conventional stomach reduction in Weight Doctors SLEEVE®.

With the endoscopic procedures pose® 3.0 Double Helix or OverStitch NXT™, the stomach volume is reduced by up to 70–75%. The procedure is minimally invasive, performed through the mouth – without external incisions, without scars, as an outpatient – and is designed to be long-term.

What does that mean in everyday life? You feel full sooner and naturally eat less – without a weekly injection. A one-off treatment instead of a monthly therapy. And where there is a medical indication in line with the guidelines, there is a chance of cost coverage by your German health insurer.

Four myths about GLP-⁠1 – and what is true

Six paths – one consultation

At Weight Doctors®, our advice is independent of any one therapy: if another treatment suits your situation better, we will recommend exactly that. With us, the conversation comes before the treatment – not the other way round.